跳至主要内容
临床试验/NCT02335086
NCT02335086已完成不适用

DNA Damage and Repair Proteins In Patients With Atherosclerotic Coronary Artery Disease

University of Surrey2 个研究点 分布在 1 个国家目标入组 126 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
126
试验地点
2
主要终点
Difference in DNA ligase activity in peripheral blood mononuclear cells of patients with stable angina and non-ST-elevation myocardial infarction

研究概览

简要总结

The purpose of this study is:

  1. To examine the association between stable and unstable coronary artery disease (CAD) with markers of DNA damage and repair,
  2. To examine the association between plaque morphology as assessed by frequency-domain optical coherence tomography (FD-OCT) and markers of DNA damage and repair in order to identify potential markers of plaque instability,
  3. To examine the association between markers of DNA damage and repair and major adverse cardiovascular events defined as death, MI and unplanned percutaneous or surgical revascularization,

详细描述

Hypotheses ----------------

We hypothesise that defective DNA damage response is an important aetiological factor in the development of CAD, underlying CAD severity and development. If this hypothesis is true, then we predict that:

  1. There is differential expression of markers of DNA damage and repair in patients with stable angina, a model of stable CAD, and patients with non ST-elevation myocardial infarction (NSTEMI), a model of unstable CAD.
  2. Differential expression of markers of DNA damage and repair correlate with plaque morphology and stability as defined by FD-OCT,
  3. Markers of DNA damage and repair can serve as distinguishing markers of stable and unstable CAD,

Methodology


研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • -----------------------
  • Presentation with ST-elevation MI (STEMI),
  • Decompensated heart failure, hypotension, shock, refractory ventricular tachycardia, acute conduction disorders, left ventricular ejection fraction ≤ 30%,
  • Prior coronary revascularization,
  • Any form of surgery up to three months prior to enrolment,
  • Active inflammatory disorders,
  • Bleeding diathesis,
  • Known allergy, hypersensitivity, or contraindication to aspirin, heparin, or thienopyridines,
  • Life expectancy less than 1 year,
  • Diabetes mellitus.
  • Angiographic:
  • Left main coronary artery stenosis ≥ 50%,
  • Coronary artery bypass surgery planned within one year of the PCI,
  • Anatomical conditions precluding three-vessel FD-OCT (significant tortuosity, severe calcification, chronic total occlusion).

结局指标

主要结局

Difference in DNA ligase activity in peripheral blood mononuclear cells of patients with stable angina and non-ST-elevation myocardial infarction

时间窗: 18 months

DNA ligase (DNA repair enzyme) activity measured using units per well, in peripheral mononuclear cells between stable and NSTEMI patients undergoing percutaneous coronary intervention.

次要结局

  • Plaque fibrous cap thickness and its association with major adverse cardiovascular events (MACE)(18 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验